\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ total\\ contact\\ cast\\ for\\ several\\ months\\ with\\ frequent\\ cast\\ changes\\.\ \(0\)\
\-\ there\\ is\\ pes\\ planus\\ deformity\\.\\ there\\ is\\ subluxation\\ at\\ the\\ talonavicular\\ joint\\.\\ subluxation\\ is\\ also\\ noted\\ at\\ the\\ talocalcaneal\\,\\ calcaneocuboid\\ and\\ cubometatarsal\\ joints\\.\\ \ \(0\)\
\-\ there\\ is\\ severe\\ hallux\\ valgus\\ deformity\\ of\\ the\\ great\\ toe\\.\\ \ \(0\)\
\-\ a\\ freiberg\\ infraction\\ is\\ noted\\ at\\ the\\ head\\ of\\ the\\ second\\ metatarsal\\.\\ there\\ are\\ no\\ periosteal\\ reaction\\.\ \(0\)\
\-\ charcot\\ arthroapathy\\ of\\ the\\ foot\\ and\\ ankle\ \(0\)\
\-\ 1\\.\\ charcot\\‚\\Ä\\ôs\\ neuropathic\\ joint\\ \ \(0\)\
\-\ 2\\.\\ trauma\\ \ \(0\)\
\-\ 3\\.\\ congenital\\ \ \(0\)\
\-\ 4\\.\\ metabolic\ \(0\)\
\-\ 31\\ year\\-old\\ woman\\ with\\ a\\ history\\ of\\ uncontrolled\\ diabetes\\ and\\ prior\\ left\\ bka\\ presents\\ with\\ right\\ foot\\ and\\ ankle\\ pain\\.\\ she\\ reports\\ multiple\\ ulcers\\ of\\ her\\ right\\ foot\\ and\\ recurrent\\ foot\\ pain\\.\\ \\ prior\\ x\\-rays\\ have\\ noted\\ right\\ foot\\ deformity\\ and\\ osteomyelitis\\.\ \(0\)\
\-\ this\\ patient\\‚\\Ä\\ôs\\ history\\ of\\ poorly\\ controlled\\ diabetes\\,\\ prior\\ foot\\ ulcers\\,\\ foot\\ pain\\ and\\ lower\\ extremity\\ swelling\\ describes\\ a\\ clinical\\ picture\\ of\\ joint\\ neuropathy\\.\\ the\\ imaging\\ studies\\ from\\ today\\ and\\ prior\\ visits\\ have\\ noted\\ foot\\ deformities\\ without\\ healing\\.\\ more\\ so\\,\\ the\\ imaging\\ studies\\ and\\ clinical\\ symptoms\\ are\\ most\\ consistent\\ with\\ charcot\\‚\\Ä\\ôs\\ neuroarthropathy\\ of\\ the\\ foot\\ and\\ ankle\\.\\ \ \(0\)\
\-\ charcot\\ neuroarthoropahty\\ is\\ a\\ progressive\\,\\ noninfectious\\,\\ destructive\\ disease\\ of\\ the\\ bones\\ and\\ joints\\ in\\ persons\\ with\\ sensory\\ neuropathy\\.\\ the\\ disease\\ can\\ affect\\ any\\ joint\\,\\ but\\ most\\ commonly\\ seen\\ in\\ the\\ joints\\ of\\ the\\ foot\\ and\\ ankle\\.\\ causes\\ include\\ alcoholism\\,\\ leprosy\\,\\ tabes\\ dorsalis\\,\\ myelomenignocele\\ and\\ congenital\\ insensitivity\\ to\\ pain\\.\\ the\\ most\\ common\\ cause\\ in\\ developed\\ countries\\ is\\ diabetes\\.\\ patients\\ with\\ type\\ 1\\ diabetes\\ commonly\\ present\\ in\\ the\\ fifth\\ decade\\ after\\ an\\ average\\ duration\\ of\\ diabetes\\ of\\ 20\\-24\\ years\\.\\ where\\ as\\ type\\ 2\\ diabetic\\ patients\\ present\\ more\\ commonly\\ with\\ charcot\\ nueuropathy\\ \\ in\\ the\\ sixth\\ decade\\ after\\ 5\\-9\\ years\\ with\\ the\\ disease\\.\\ charcot\\ nueroarthorpathy\\ is\\ seen\\ in\\ approximately\\ 0\\.1\\-2\\.5\\%\\ of\\ diabetic\\ patients\\,\\ but\\ it\\ is\\ largely\\ believed\\ that\\ the\\ occurrence\\ is\\ on\\ the\\ rise\\.\\ bilateral\\ disease\\ is\\ seen\\ in\\ approxametely\\ 10\\%\\ of\\ patients\\ with\\ a\\ recurrence\\ rate\\ of\\ less\\ than\\ 5\\%\\.\ \(0\)\
\-\ there\\ is\\ little\\ understanding\\ of\\ the\\ disease\\ process\\ of\\ charcot\\‚\\Ä\\ôs\\ arthopathy\\,\\ but\\ three\\ theories\\ have\\ been\\ hypothesized\\.\\ the\\ nuerotraumatic\\ theory\\ is\\ associated\\ with\\ exaggerated\\ overuse\\ injury\\ causing\\ microtrauma\\ or\\ a\\ single\\ traumatic\\ event\\ in\\ an\\ insensate\\ joint\\ that\\ leads\\ to\\ charcot\\ deformities\\.\\ the\\ neurovascular\\ theory\\ proposes\\ that\\ the\\ autonomic\\ dysfunction\\ causes\\ an\\ increase\\ in\\ arteriovenous\\ shunting\\ leading\\ to\\ increased\\ blood\\ flow\\.\\ thus\\,\\ amplifying\\ bone\\ resorption\\ and\\ weakening\\.\\ the\\ last\\ theory\\ involves\\ the\\ escalation\\ of\\ osteoclast\\ cells\\ due\\ to\\ the\\ action\\ of\\ inflammatory\\ cytokines\\.\\ the\\ literatures\\ now\\ suggest\\ that\\ charcot\\ arthorpathy\\ is\\ most\\ likely\\ due\\ from\\ a\\ combination\\ of\\ the\\ three\\ described\\ theories\\.\\ \ \(0\)\
\-\ the\\ clinical\\ presentation\\ of\\ charcot\\ arthropathy\\ can\\ vary\\ widely\\ depending\\ on\\ the\\ stage\\ of\\ the\\ disease\\.\\ acute\\ charoct\\ nueroarthropathy\\ of\\ the\\ foot\\ and\\ ankle\\ presents\\ with\\ one\\ or\\ more\\ of\\ the\\ following\\ symptoms\\:\\ swelling\\,\\ an\\ increase\\ in\\ local\\ skin\\ temperature\\ \\(3\\-7\\¬\\∞\\)\\,\\ erythema\\,\\ joint\\ effusion\\ and\\ an\\ insensate\\ foot\\.\\ the\\ majority\\ of\\ patients\\ will\\ have\\ mild\\ to\\ moderate\\ foot\\ pain\\ and\\ some\\ will\\ have\\ associated\\ foot\\ ulcers\\.\\ patients\\ may\\ report\\ to\\ clinic\\ following\\ a\\ traumatic\\ event\\,\\ but\\ most\\ patients\\ are\\ unable\\ to\\ identify\\ an\\ event\\ causing\\ foot\\ trauma\\.\\ on\\ physical\\ exam\\ the\\ patient\\ will\\ have\\ dependent\\ rubor\\,\\ bounding\\ pulses\\ and\\ passive\\ motion\\ of\\ the\\ foot\\/ankle\\ may\\ reveal\\ a\\ \\‚\\Ä\\úloose\\ bag\\ of\\ bones\\.\\‚\\Ä\\ù\\ the\\ acute\\ presentation\\ of\\ charcot\\ arthropathy\\ is\\ similar\\ to\\ the\\ clinical\\ presentation\\ of\\ osteomylitis\\ and\\ cellulitis\\.\\ these\\ conditions\\ must\\ be\\ ruled\\ out\\ by\\ the\\ clinical\\ physician\\ and\\ with\\ the\\ use\\ radiographic\\ imaging\\ and\\ labs\\.\\ \ \(0\)\
\-\ there\\ are\\ several\\ ways\\ to\\ stage\\ the\\ disease\\ process\\ of\\ charcot\\‚\\Ä\\ôs\\ arthropathy\\.\\ two\\ of\\ theses\\ classifications\\ will\\ be\\ discussed\\ here\\.\\ the\\ eichenholtz\\ classification\\ is\\ four\\ stages\\ that\\ combine\\ the\\ physical\\ exam\\ and\\ radiographic\\ findings\\ to\\ guide\\ treatment\\.\\ stage\\ 0\\ is\\ a\\ patient\\ presenting\\ with\\ acute\\ charcot\\ nueroarthropathy\\ as\\ described\\ above\\,\\ but\\ with\\ normal\\ radiographs\\.\\ stage\\ 1\\ is\\ the\\ fragmentation\\ or\\ dissolution\\ phase\\ in\\ which\\ there\\ will\\ be\\ similar\\ physical\\ exam\\ findings\\ as\\ in\\ stage\\ 0\\,\\ but\\ plain\\ radiographs\\ will\\ show\\ osteopenia\\,\\ periarticular\\ fragmentation\\ and\\ subluxation\\ or\\ dislocation\\ of\\ the\\ joints\\.\\ stage\\ 2\\ is\\ the\\ coalescence\\ phase\\ describing\\ the\\ early\\ healing\\ phase\\.\\ there\\ is\\ less\\ swelling\\,\\ but\\ plain\\ radiographs\\ demonstrate\\ absorption\\ of\\ debris\\,\\ fusion\\ of\\ bony\\ fragments\\ and\\ early\\ sclerosis\\.\\ stage\\ 3\\ is\\ the\\ reconstruction\\ phase\\ with\\ no\\ inflammation\\ and\\ stable\\ joints\\ on\\ physical\\ exam\\.\\ at\\ this\\ stage\\,\\ the\\ plain\\ radiographs\\ exhibit\\ joint\\ arthrosis\\,\\ osteophytes\\,\\ and\\ subchondral\\ sclerosis\\.\\ \ \(0\)\
\-\ the\\ bodsky\\ anatomic\\ classification\\ of\\ the\\ charcot\\ foot\\ stages\\ the\\ specific\\ pattern\\ of\\ collapse\\.\\ type\\ 1\\,\\ the\\ most\\ common\\,\\ involves\\ the\\ collapse\\ of\\ the\\ tarsometatarsal\\ joint\\.\\ this\\ deformity\\ can\\ cause\\ a\\ fixed\\ rocker\\-bottom\\ foot\\ with\\ valgus\\ angulation\\.\\ type\\ 2\\ collapse\\ affects\\ the\\ subtalar\\ and\\ chopart\\ joints\\.\\ type\\ 3\\ collapse\\ involves\\ the\\ ankle\\ joint\\.\\ this\\ type\\ of\\ collapse\\ is\\ more\\ likely\\ to\\ cause\\ recurrent\\ ulceration\\ and\\ osteomyelitis\\ over\\ the\\ malleoli\\.\ \(0\)\
\-\ traditionally\\,\\ serial\\ plain\\ radiographs\\ are\\ used\\ to\\ follow\\ the\\ progression\\ of\\ charcot\\ arthropathy\\.\\ futher\\ imaging\\ is\\ warranted\\ if\\ there\\ is\\ clinical\\ suspicion\\ for\\ osteomyelitis\\.\\ a\\ three\\ phase\\ tc\\-99m\\ methylene\\ diphosponate\\ scintigraphy\\,\\ followed\\ by\\ indium\\ in\\-111\\-labeled\\ leukocyte\\ scintigraphy\\,\\ has\\ been\\ found\\ to\\ have\\ a\\ sensitivity\\ of\\ 93\\%\\ to\\ 100\\%\\ and\\ a\\ specificity\\ of\\ approximately\\ 80\\%\\ for\\ osteomyelitis\\.\\ mri\\ has\\ been\\ found\\ to\\ be\\ less\\ specific\\ for\\ osteomyelitis\\.\\ \\ with\\ this\\ said\\,\\ mri\\ was\\ found\\ to\\ be\\ most\\ helpful\\ in\\ recognizing\\ charcot\\ arthropathy\\ during\\ stage\\ 0\\ when\\ there\\ are\\ normal\\ plain\\ radiographs\\.\\ mri\\ is\\ useful\\ in\\ identifying\\ bone\\ marrow\\ edema\\ and\\ stress\\ bone\\ injury\\ prior\\ to\\ any\\ abnormalities\\ can\\ be\\ seen\\ on\\ plain\\ radiographs\\.\\ \\ \ \(0\)\
\-\ the\\ management\\ and\\ treatment\\ of\\ charcot\\ arthopathy\\ varies\\ on\\ the\\ degree\\ of\\ progression\\ and\\ severity\\.\\ the\\ classification\\ systems\\,\\ like\\ the\\ ones\\ described\\ above\\,\\ provide\\ treatment\\ protocols\\ for\\ different\\ stages\\ of\\ the\\ disease\\ process\\ and\\ joint\\ locations\\.\\ it\\ is\\ important\\ to\\ recognize\\ that\\ every\\ patient\\ will\\ heal\\ differently\\,\\ so\\ the\\ clinical\\ physician\\ must\\ vary\\ treatment\\ protocols\\ as\\ needed\\.\\ conservative\\ management\\ is\\ the\\ primary\\ goal\\ in\\ the\\ management\\ of\\ charcot\\ arthopathy\\.\\ immobilization\\ is\\ the\\ mainstay\\ of\\ the\\ treatment\\.\\ a\\ total\\-contact\\ cast\\ is\\ the\\ most\\ widely\\ used\\ method\\ for\\ immobilization\\ with\\ frequent\\ cast\\ changes\\ to\\ reduce\\ complications\\.\\ following\\ removal\\ of\\ a\\ cast\\,\\ life\\ long\\ protection\\ of\\ the\\ foot\\ and\\ ankle\\ is\\ provided\\ by\\ specialized\\ foot\\ braces\\ and\\ shoes\\.\\ operative\\ management\\ is\\ avoided\\ in\\ most\\ cases\\,\\ but\\ is\\ used\\ in\\ approximately\\ 25\\%\\ of\\ cases\\.\\ there\\ is\\ only\\ a\\ little\\ amount\\ of\\ literature\\ to\\ support\\ the\\ different\\ types\\ of\\ surgery\\ to\\ correct\\ charcot\\ arthropathy\\.\\ a\\ surgeon\\ will\\ consider\\ internal\\ fixation\\,\\ external\\ fixation\\,\\ exostectomy\\ and\\/or\\ arthrodesis\\ with\\ the\\ hopes\\ of\\ preventing\\ infection\\,\\ recurrent\\ ulcerations\\,\\ instability\\ and\\ the\\ need\\ for\\ an\\ amputation\\.\\ other\\ methods\\ of\\ treatment\\ are\\ under\\ investigation\\.\\ those\\ include\\ pharmacologic\\ treatment\\ such\\ as\\ bisphosphonates\\ and\\ calitonin\\,\\ low\\-intensity\\ ultrasound\\ and\\ electrical\\ stimulation\\.\\ \ \(0\)\
\-\ the\\ prognosis\\ for\\ charcot\\ arthorpathy\\ is\\ more\\ favorable\\ for\\ those\\ with\\ immediate\\ diagnosis\\ and\\ treatment\\.\\ outcomes\\ are\\ more\\ encouraging\\ for\\ forefoot\\ arthropathies\\ than\\ those\\ of\\ the\\ midfoot\\,\\ hindfoot\\ or\\ ankle\\.\\ the\\ healing\\ process\\ is\\ prolonged\\ by\\ ulcers\\,\\ infection\\ and\\ the\\ need\\ for\\ operative\\ intervention\\.\\ a\\ patient\\ suffering\\ from\\ a\\ non\\-complicated\\ charcot\\ arthropathy\\,\\ in\\ general\\,\\ will\\ recover\\ in\\ 1\\-2\\ years\\ if\\ there\\ is\\ a\\ timely\\ diagnosis\\,\\ appropriate\\ immobilization\\ and\\ long\\-term\\ preventative\\ measures\\ are\\ undertaken\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ charcot\\:\\ 0\\.5005149369269957\ \(0\)\
\-\ foot\\:\\ 0\\.2859799899399751\ \(0\)\
\-\ the\\:\\ 0\\.28164576748103043\ \(0\)\
\-\ of\\:\\ 0\\.19123246210432768\ \(0\)\
\-\ is\\:\\ 0\\.17840740413932396\ \(0\)\
\-\ and\\:\\ 0\\.15705285053362192\ \(0\)\
\-\ ankle\\:\\ 0\\.14379862017448483\ \(0\)\
\-\ stage\\:\\ 0\\.1296979380061529\ \(0\)\
\-\ arthropathy\\:\\ 0\\.1281888673007865\ \(0\)\
\-\ joint\\:\\ 0\\.11924451754353843\ \(0\)\
\-\ will\\:\\ 0\\.10482465739935411\ \(0\)\
\-\ to\\:\\ 0\\.09500418678533437\ \(0\)\
\-\ cast\\:\\ 0\\.09396225640401092\ \(0\)\
\-\ joints\\:\\ 0\\.09332410545688233\ \(0\)\
\-\ in\\:\\ 0\\.09003483464260703\ \(0\)\
\-\ arthopathy\\:\\ 0\\.08681918337958715\ \(0\)\
\-\ there\\:\\ 0\\.08640495565367258\ \(0\)\
\-\ collapse\\:\\ 0\\.08485624956402849\ \(0\)\
\-\ most\\:\\ 0\\.08476018997709911\ \(0\)\
\-\ diabetes\\:\\ 0\\.08264731690197087\ \(0\)\
\-\ radiographs\\:\\ 0\\.0821585853587649\ \(0\)\
\-\ clinical\\:\\ 0\\.08027954742494046\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.0780050802767882\ \(0\)\
\-\ phase\\:\\ 0\\.07742400077052758\ \(0\)\
\-\ ulcers\\:\\ 0\\.07625040297946006\ \(0\)\
\-\ type\\:\\ 0\\.07283764826226444\ \(0\)\
\-\ plain\\:\\ 0\\.07163607236133412\ \(0\)\
\-\ but\\:\\ 0\\.0715887054547542\ \(0\)\
\-\ patients\\:\\ 0\\.07126062769998628\ \(0\)\
\-\ with\\:\\ 0\\.07086915683513587\ \(0\)\
\-\ treatment\\:\\ 0\\.06896135746125122\ \(0\)\
\-\ theory\\:\\ 0\\.06829992152466804\ \(0\)\
\-\ have\\:\\ 0\\.06328023377664917\ \(0\)\
\-\ are\\:\\ 0\\.0618000880677698\ \(0\)\
\-\ disease\\:\\ 0\\.060769060427515724\ \(0\)\
\-\ for\\:\\ 0\\.06033293857517854\ \(0\)\
\-\ more\\:\\ 0\\.059620422674086286\ \(0\)\
\-\ deformity\\:\\ 0\\.05916254512949022\ \(0\)\
\-\ stages\\:\\ 0\\.05807374546367045\ \(0\)\
\-\ insensate\\:\\ 0\\.05787945558639144\ \(0\)\
\-\ arthorpathy\\:\\ 0\\.05787945558639144\ \(0\)\
\-\ nueroarthropathy\\:\\ 0\\.05787945558639144\ \(0\)\
\-\ classification\\:\\ 0\\.055811820081997324\ \(0\)\
\-\ subluxation\\:\\ 0\\.0544499267816679\ \(0\)\
\-\ process\\:\\ 0\\.054289290442420764\ \(0\)\
\-\ event\\:\\ 0\\.05413786544865612\ \(0\)\
\-\ management\\:\\ 0\\.0534672160914603\ \(0\)\
\-\ immobilization\\:\\ 0\\.052982871991794536\ \(0\)\
\-\ healing\\:\\ 0\\.050697444564504535\ \(0\)\
\-\ prior\\:\\ 0\\.05062421625070516\ \(0\)\
\-\ theories\\:\\ 0\\.04908386335618126\ \(0\)\
\-\ protocols\\:\\ 0\\.04908386335618126\ \(0\)\
\-\ an\\:\\ 0\\.048439423429101555\ \(0\)\
\-\ involves\\:\\ 0\\.047239018343641366\ \(0\)\
\-\ that\\:\\ 0\\.047118375087106965\ \(0\)\
\-\ those\\:\\ 0\\.046454400462316546\ \(0\)\
\-\ fragmentation\\:\\ 0\\.04509554341798878\ \(0\)\
\-\ described\\:\\ 0\\.04404743362512241\ \(0\)\
\-\ be\\:\\ 0\\.04404537523708268\ \(0\)\
\-\ recurrent\\:\\ 0\\.04353007702016131\ \(0\)\
\-\ widely\\:\\ 0\\.04185451899099853\ \(0\)\
\-\ vary\\:\\ 0\\.04069774730288369\ \(0\)\
\-\ used\\:\\ 0\\.040642324170983735\ \(0\)\
\-\ valgus\\:\\ 0\\.04028827112597108\ \(0\)\
\-\ commonly\\:\\ 0\\.0401709088203421\ \(0\)\
\-\ contact\\:\\ 0\\.039719710776301445\ \(0\)\
\-\ neuropathy\\:\\ 0\\.03954097561476886\ \(0\)\
\-\ physical\\:\\ 0\\.03924865199284462\ \(0\)\
\-\ diabetic\\:\\ 0\\.03841364564373598\ \(0\)\
\-\ noted\\:\\ 0\\.03837826781196453\ \(0\)\
\-\ decade\\:\\ 0\\.03812520148973003\ \(0\)\
\-\ imaging\\:\\ 0\\.038040615324088235\ \(0\)\
\-\ can\\:\\ 0\\.0379852031954561\ \(0\)\
\-\ or\\:\\ 0\\.037772028098902836\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.03758490256160437\ \(0\)\
\-\ presentation\\:\\ 0\\.037371320204634136\ \(0\)\
\-\ cause\\:\\ 0\\.036983871124900966\ \(0\)\
\-\ less\\:\\ 0\\.03693338284750368\ \(0\)\
\-\ deformities\\:\\ 0\\.03673768878623518\ \(0\)\
\-\ swelling\\:\\ 0\\.03653883855848477\ \(0\)\
\-\ three\\:\\ 0\\.03644270624647306\ \(0\)\
\-\ exam\\:\\ 0\\.03643849974953324\ \(0\)\
\-\ as\\:\\ 0\\.03634938423904401\ \(0\)\
\-\ little\\:\\ 0\\.03559982822582036\ \(0\)\
\-\ found\\:\\ 0\\.03512715566572382\ \(0\)\
\-\ approximately\\:\\ 0\\.03464003776753641\ \(0\)\
\-\ seen\\:\\ 0\\.03407813587938591\ \(0\)\
\-\ fixation\\:\\ 0\\.033798296376336356\ \(0\)\
\-\ need\\:\\ 0\\.03331792919771234\ \(0\)\
\-\ years\\:\\ 0\\.033278144467206984\ \(0\)\
\-\ frequent\\:\\ 0\\.033187106446499276\ \(0\)\
\-\ progression\\:\\ 0\\.033187106446499276\ \(0\)\
\-\ different\\:\\ 0\\.03312269291206422\ \(0\)\
\-\ on\\:\\ 0\\.03279213780294645\ \(0\)\
\-\ following\\:\\ 0\\.03256795945947791\ \(0\)\
\-\ pain\\:\\ 0\\.03237739183443389\ \(0\)\
\-\ physician\\:\\ 0\\.03174548838085489\ \(0\)\
\-\ been\\:\\ 0\\.03162911438229568\ \(0\)\
\-\ this\\:\\ 0\\.03109086282504512\ \(0\)\
\-\ must\\:\\ 0\\.031015410461347984\ \(0\)\
\-\ by\\:\\ 0\\.030738746438256113\ \(0\)\
\-\ so\\:\\ 0\\.030444223459334434\ \(0\)\
\-\ operative\\:\\ 0\\.030360739641091882\ \(0\)\
\-\ causing\\:\\ 0\\.0297296928682536\ \(0\)\
\-\ total\\:\\ 0\\.029655048729108815\ \(0\)\
\-\ bone\\:\\ 0\\.02962151582791006\ \(0\)\
\-\ patient\\:\\ 0\\.029428890888919642\ \(0\)\
\-\ acute\\:\\ 0\\.02936802094414938\ \(0\)\
\-\ bones\\:\\ 0\\.029121568370845327\ \(0\)\
\-\ increase\\:\\ 0\\.029053710198372402\ \(0\)\
\-\ cubometatarsal\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ arthroapathy\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ neuroarthoropahty\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ myelomenignocele\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ nueuropathy\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ nueroarthorpathy\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ approxametely\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ nuerotraumatic\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ amplifying\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ escalation\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ literatures\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ charoct\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ bounding\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ theses\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ eichenholtz\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ bodsky\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ diphosponate\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ exostectomy\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ calitonin\\:\\ 0\\.02893972779319572\ \(0\)\
\-\ mri\\:\\ 0\\.027866915964217778\ \(0\)\
\-\ calcaneocuboid\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ neuroarthropathy\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ tabes\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ proposes\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ rubor\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ osteomylitis\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ chopart\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ futher\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ differently\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ preventative\\:\\ 0\\.02765345488661889\ \(0\)\
\-\ similar\\:\\ 0\\.02758416728843027\ \(0\)\
\-\ traumatic\\:\\ 0\\.027425542060202795\ \(0\)\
\-\ specific\\:\\ 0\\.027425542060202795\ \(0\)\
\-\ causes\\:\\ 0\\.0273476922657498\ \(0\)\
\-\ at\\:\\ 0\\.027340621731470796\ \(0\)\
\-\ radiographic\\:\\ 0\\.026851761900575134\ \(0\)\
\-\ leprosy\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ cytokines\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ tarsometatarsal\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ encouraging\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ arthropathies\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ timely\\:\\ 0\\.026740829735643172\ \(0\)\
\-\ studies\\:\\ 0\\.02654902255769167\ \(0\)\
\-\ above\\:\\ 0\\.026109769088090356\ \(0\)\
\-\ early\\:\\ 0\\.026088584832529595\ \(0\)\
\-\ bka\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ countries\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ osteoclast\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ combine\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ dissolution\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ coalescence\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ specialized\\:\\ 0\\.026032942673123765\ \(0\)\
\-\ congenital\\:\\ 0\\.026004548125205956\ \(0\)\
\-\ sclerosis\\:\\ 0\\.025779026919783947\ \(0\)\
\-\ persons\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ insensitivity\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ hypothesized\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ autonomic\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ weakening\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ malleoli\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ methylene\\:\\ 0\\.025454556829066347\ \(0\)\
\-\ describing\\:\\ 0\\.024965538565775224\ \(0\)\
\-\ protection\\:\\ 0\\.024965538565775224\ \(0\)\
\-\ braces\\:\\ 0\\.024965538565775224\ \(0\)\
\-\ recognizing\\:\\ 0\\.02454193167809063\ \(0\)\
\-\ arthrodesis\\:\\ 0\\.02454193167809063\ \(0\)\
\-\ pharmacologic\\:\\ 0\\.02454193167809063\ \(0\)\
\-\ hindfoot\\:\\ 0\\.02454193167809063\ \(0\)\
\-\ cases\\:\\ 0\\.024343142861440015\ \(0\)\
\-\ talonavicular\\:\\ 0\\.024168283922489518\ \(0\)\
\-\ classifications\\:\\ 0\\.024168283922489518\ \(0\)\
\-\ arthrosis\\:\\ 0\\.024168283922489518\ \(0\)\
\-\ mainstay\\:\\ 0\\.024168283922489518\ \(0\)\
\-\ shoes\\:\\ 0\\.024168283922489518\ \(0\)\
\-\ long\\:\\ 0\\.023999258379952287\ \(0\)\
\-\ talocalcaneal\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ freiberg\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ infraction\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ dorsalis\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ understanding\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ ways\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ hopes\\:\\ 0\\.023834044615571218\ \(0\)\
\-\ several\\:\\ 0\\.023745735729157995\ \(0\)\
\-\ injury\\:\\ 0\\.02360120376984348\ \(0\)\
\-\ hallux\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ overuse\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ microtrauma\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ ones\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ avoided\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ ulcerations\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ forefoot\\:\\ 0\\.023531688384290858\ \(0\)\
\-\ any\\:\\ 0\\.023390397712833137\ \(0\)\
\-\ planus\\:\\ 0\\.023255658771513803\ \(0\)\
\-\ noninfectious\\:\\ 0\\.023255658771513803\ \(0\)\
\-\ traditionally\\:\\ 0\\.023255658771513803\ \(0\)\
\-\ bisphosphonates\\:\\ 0\\.023255658771513803\ \(0\)\
\-\ midfoot\\:\\ 0\\.023255658771513803\ \(0\)\
\-\ pes\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ exaggerated\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ absorption\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ subtalar\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ suffering\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ recover\\:\\ 0\\.023001736142437532\ \(0\)\
\-\ neurovascular\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ bag\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ guide\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ said\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ electrical\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ undertaken\\:\\ 0\\.02254777170899439\ \(0\)\
\-\ uncontrolled\\:\\ 0\\.022343033620538088\ \(0\)\
\-\ visits\\:\\ 0\\.022343033620538088\ \(0\)\
\-\ alcoholism\\:\\ 0\\.022343033620538088\ \(0\)\
\-\ indium\\:\\ 0\\.022343033620538088\ \(0\)\
\-\ changes\\:\\ 0\\.0218731504458727\ \(0\)\
\-\ infection\\:\\ 0\\.021862276957956655\ \(0\)\
\-\ recognize\\:\\ 0\\.021797866292813155\ \(0\)\
\-\ action\\:\\ 0\\.021635146558018674\ \(0\)\
\-\ methods\\:\\ 0\\.021635146558018674\ \(0\)\
\-\ outcomes\\:\\ 0\\.021635146558018674\ \(0\)\
\-\ likely\\:\\ 0\\.021627657065738756\ \(0\)\
\-\ from\\:\\ 0\\.021561103828235523\ \(0\)\
\-\ include\\:\\ 0\\.021534122025605888\ \(0\)\
\-\ leukocyte\\:\\ 0\\.02148036760164585\ \(0\)\
\-\ heal\\:\\ 0\\.02148036760164585\ \(0\)\
\-\ preventing\\:\\ 0\\.02148036760164585\ \(0\)\
\-\ periarticular\\:\\ 0\\.021332790326738314\ \(0\)\
\-\ neuropathic\\:\\ 0\\.02119177425235591\ \(0\)\
\-\ investigation\\:\\ 0\\.02119177425235591\ \(0\)\
\-\ if\\:\\ 0\\.02102865795668982\ \(0\)\
\-\ trauma\\:\\ 0\\.021019138557085433\ \(0\)\
\-\ sixth\\:\\ 0\\.020927259495499263\ \(0\)\
\-\ exhibit\\:\\ 0\\.020927259495499263\ \(0\)\
\-\ due\\:\\ 0\\.020804044106098984\ \(0\)\
\-\ today\\:\\ 0\\.02080283808488499\ \(0\)\
\-\ occurrence\\:\\ 0\\.02080283808488499\ \(0\)\
\-\ varies\\:\\ 0\\.02080283808488499\ \(0\)\
\-\ amputation\\:\\ 0\\.02080283808488499\ \(0\)\
\-\ largely\\:\\ 0\\.020683112958360145\ \(0\)\
\-\ specificity\\:\\ 0\\.020683112958360145\ \(0\)\
\-\ favorable\\:\\ 0\\.020683112958360145\ \(0\)\
\-\ rise\\:\\ 0\\.020567742450670137\ \(0\)\
\-\ goal\\:\\ 0\\.020567742450670137\ \(0\)\
\-\ common\\:\\ 0\\.02052521108945596\ \(0\)\
\-\ than\\:\\ 0\\.020516417354651\ \(0\)\
\-\ shunting\\:\\ 0\\.020348873651441845\ \(0\)\
\-\ resorption\\:\\ 0\\.020348873651441845\ \(0\)\
\-\ warranted\\:\\ 0\\.020244853207104584\ \(0\)\
\-\ 93\\:\\ 0\\.02014413556298554\ \(0\)\
\-\ identifying\\:\\ 0\\.020046517420161482\ \(0\)\
\-\ method\\:\\ 0\\.019951813691252145\ \(0\)\
\-\ stimulation\\:\\ 0\\.019951813691252145\ \(0\)\
\-\ symptoms\\:\\ 0\\.019802406763787327\ \(0\)\
\-\ ulceration\\:\\ 0\\.01977048780738443\ \(0\)\
\-\ describes\\:\\ 0\\.019598968235260607\ \(0\)\
\-\ believed\\:\\ 0\\.01935791515455682\ \(0\)\
\-\ passive\\:\\ 0\\.01935791515455682\ \(0\)\
\-\ destructive\\:\\ 0\\.019281469544093304\ \(0\)\
\-\ identify\\:\\ 0\\.019281469544093304\ \(0\)\
\-\ osteophytes\\:\\ 0\\.019281469544093304\ \(0\)\
\-\ debris\\:\\ 0\\.01920682282186799\ \(0\)\
\-\ associated\\:\\ 0\\.019076085415970598\ \(0\)\
\-\ picture\\:\\ 0\\.018992876194803367\ \(0\)\
\-\ cellulitis\\:\\ 0\\.018992876194803367\ \(0\)\
\-\ correct\\:\\ 0\\.018992876194803367\ \(0\)\
\-\ locations\\:\\ 0\\.018924651214291287\ \(0\)\
\-\ controlled\\:\\ 0\\.01885786265640871\ \(0\)\
\-\ average\\:\\ 0\\.01885786265640871\ \(0\)\
\-\ loose\\:\\ 0\\.01885786265640871\ \(0\)\
\-\ osteopenia\\:\\ 0\\.018792451280802185\ \(0\)\
\-\ reconstruction\\:\\ 0\\.018792451280802185\ \(0\)\
\-\ angulation\\:\\ 0\\.018792451280802185\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01876186058234803\ \(0\)\
\-\ toe\\:\\ 0\\.018728361437946716\ \(0\)\
\-\ affect\\:\\ 0\\.018728361437946716\ \(0\)\
\-\ fixed\\:\\ 0\\.018665540784675316\ \(0\)\
\-\ present\\:\\ 0\\.018571473115159907\ \(0\)\
\-\ affects\\:\\ 0\\.01854351268939376\ \(0\)\
\-\ it\\:\\ 0\\.018526360938794666\ \(0\)\
\-\ temperature\\:\\ 0\\.018426005206666356\ \(0\)\
\-\ reduce\\:\\ 0\\.018426005206666356\ \(0\)\
\-\ sensitivity\\:\\ 0\\.01836884439311759\ \(0\)\
\-\ provide\\:\\ 0\\.018312695328683782\ \(0\)\
\-\ leads\\:\\ 0\\.018257522819382525\ \(0\)\
\-\ may\\:\\ 0\\.018213134521381274\ \(0\)\
\-\ ruled\\:\\ 0\\.018097539039326885\ \(0\)\
\-\ right\\:\\ 0\\.017998895019289342\ \(0\)\
\-\ metatarsal\\:\\ 0\\.017995196637516475\ \(0\)\
\-\ fifth\\:\\ 0\\.017995196637516475\ \(0\)\
\-\ discussed\\:\\ 0\\.017945237505432997\ \(0\)\
\-\ great\\:\\ 0\\.01789605296481303\ \(0\)\
\-\ findings\\:\\ 0\\.01786237913581028\ \(0\)\
\-\ severity\\:\\ 0\\.017847619362608938\ \(0\)\
\-\ consider\\:\\ 0\\.01779991411291018\ \(0\)\
\-\ literature\\:\\ 0\\.01766095733059818\ \(0\)\
\-\ dysfunction\\:\\ 0\\.017571589749831886\ \(0\)\
\-\ support\\:\\ 0\\.017571589749831886\ \(0\)\
\-\ surgeon\\:\\ 0\\.017571589749831886\ \(0\)\
\-\ after\\:\\ 0\\.01755750496459717\ \(0\)\
\-\ every\\:\\ 0\\.017527832651635957\ \(0\)\
\-\ prolonged\\:\\ 0\\.017527832651635957\ \(0\)\
\-\ systems\\:\\ 0\\.017484670906603657\ \(0\)\
\-\ duration\\:\\ 0\\.017442088531369887\ \(0\)\
\-\ dependent\\:\\ 0\\.017442088531369887\ \(0\)\
\-\ presents\\:\\ 0\\.017410391183233856\ \(0\)\
\-\ arteriovenous\\:\\ 0\\.017358601099317816\ \(0\)\
\-\ fragments\\:\\ 0\\.017317667120755616\ \(0\)\
\-\ subchondral\\:\\ 0\\.017317667120755616\ \(0\)\
\-\ immediate\\:\\ 0\\.017317667120755616\ \(0\)\
\-\ useful\\:\\ 0\\.01727725460834451\ \(0\)\
\-\ depending\\:\\ 0\\.017237350442913586\ \(0\)\
\-\ here\\:\\ 0\\.017237350442913586\ \(0\)\
\-\ suspicion\\:\\ 0\\.01719794199423077\ \(0\)\
\-\ pulses\\:\\ 0\\.017159017097004275\ \(0\)\
\-\ helpful\\:\\ 0\\.017159017097004275\ \(0\)\
\-\ sensory\\:\\ 0\\.017045028571180187\ \(0\)\
\-\ instability\\:\\ 0\\.017045028571180187\ \(0\)\
\-\ types\\:\\ 0\\.01682864885746449\ \(0\)\
\-\ combination\\:\\ 0\\.016793978137250823\ \(0\)\
\-\ anatomic\\:\\ 0\\.016793978137250823\ \(0\)\
\-\ serial\\:\\ 0\\.01665896459885617\ \(0\)\
\-\ thus\\:\\ 0\\.0166260903220469\ \(0\)\
\-\ has\\:\\ 0\\.016531613447940074\ \(0\)\
\-\ conditions\\:\\ 0\\.016529463380394172\ \(0\)\
\-\ majority\\:\\ 0\\.01643569282970102\ \(0\)\
\-\ metabolic\\:\\ 0\\.016405041969779897\ \(0\)\
\-\ erythema\\:\\ 0\\.01637468442402135\ \(0\)\
\-\ poorly\\:\\ 0\\.01634461463184121\ \(0\)\
\-\ leading\\:\\ 0\\.01608609107473141\ \(0\)\
\-\ 31\\:\\ 0\\.016058624761829978\ \(0\)\
\-\ periosteal\\:\\ 0\\.01592475091783345\ \(0\)\
\-\ prognosis\\:\\ 0\\.01592475091783345\ \(0\)\
\-\ appropriate\\:\\ 0\\.01589864098177434\ \(0\)\
\-\ degree\\:\\ 0\\.01582157631787476\ \(0\)\
\-\ dislocation\\:\\ 0\\.015697154907260487\ \(0\)\
\-\ unable\\:\\ 0\\.01567284567472218\ \(0\)\
\-\ local\\:\\ 0\\.015577429780735643\ \(0\)\
\-\ reaction\\:\\ 0\\.015394798675980124\ \(0\)\
\-\ important\\:\\ 0\\.015328934594083413\ \(0\)\
\-\ report\\:\\ 0\\.015243190473817343\ \(0\)\
\-\ clinic\\:\\ 0\\.015243190473817343\ \(0\)\
\-\ reveal\\:\\ 0\\.015222111729667217\ \(0\)\
\-\ fusion\\:\\ 0\\.015201172120155518\ \(0\)\
\-\ intervention\\:\\ 0\\.015201172120155518\ \(0\)\
\-\ marrow\\:\\ 0\\.01503845238536104\ \(0\)\
\-\ under\\:\\ 0\\.014979521786927854\ \(0\)\
\-\ recurrence\\:\\ 0\\.014940834242536984\ \(0\)\
\-\ stress\\:\\ 0\\.014940834242536984\ \(0\)\
\-\ needed\\:\\ 0\\.014940834242536984\ \(0\)\
\-\ 100\\:\\ 0\\.014846130513627643\ \(0\)\
\-\ life\\:\\ 0\\.014846130513627643\ \(0\)\
\-\ provided\\:\\ 0\\.014846130513627643\ \(0\)\
\-\ normal\\:\\ 0\\.014777096081988069\ \(0\)\
\-\ measures\\:\\ 0\\.014754172210526221\ \(0\)\
\-\ last\\:\\ 0\\.014718122512102161\ \(0\)\
\-\ suggest\\:\\ 0\\.014700250130615633\ \(0\)\
\-\ four\\:\\ 0\\.014664804629759925\ \(0\)\
\-\ external\\:\\ 0\\.014629750799911946\ \(0\)\
\-\ inflammation\\:\\ 0\\.014543774282347282\ \(0\)\
\-\ general\\:\\ 0\\.014526855099186201\ \(0\)\
\-\ amount\\:\\ 0\\.014476632319537802\ \(0\)\
\-\ stable\\:\\ 0\\.014314743148780807\ \(0\)\
\-\ where\\:\\ 0\\.014221432324097165\ \(0\)\
\-\ presenting\\:\\ 0\\.014175786366468806\ \(0\)\
\-\ 80\\:\\ 0\\.014115929131743634\ \(0\)\
\-\ reports\\:\\ 0\\.014071765922131541\ \(0\)\
\-\ motion\\:\\ 0\\.014028209091561267\ \(0\)\
\-\ conservative\\:\\ 0\\.013971048278012502\ \(0\)\
\-\ cells\\:\\ 0\\.013942849520580235\ \(0\)\
\-\ bony\\:\\ 0\\.013942849520580235\ \(0\)\
\-\ single\\:\\ 0\\.013914899213578693\ \(0\)\
\-\ progressive\\:\\ 0\\.013859726704277438\ \(0\)\
\-\ complications\\:\\ 0\\.013859726704277438\ \(0\)\
\-\ use\\:\\ 0\\.013846082213036334\ \(0\)\
\-\ removal\\:\\ 0\\.013832496156626241\ \(0\)\
\-\ history\\:\\ 0\\.013827575013051057\ \(0\)\
\-\ rate\\:\\ 0\\.013712771030101397\ \(0\)\
\-\ moderate\\:\\ 0\\.013584836785898504\ \(0\)\
\-\ second\\:\\ 0\\.013547441390327911\ \(0\)\
\-\ pattern\\:\\ 0\\.01351048167918316\ \(0\)\
\-\ skin\\:\\ 0\\.013461862500371157\ \(0\)\
\-\ like\\:\\ 0\\.013449823247503849\ \(0\)\
\-\ effusion\\:\\ 0\\.013437829511769256\ \(0\)\
\-\ developed\\:\\ 0\\.013425880950287567\ \(0\)\
\-\ abnormalities\\:\\ 0\\.013108382259120263\ \(0\)\
\-\ extremity\\:\\ 0\\.013033735536894946\ \(0\)\
\-\ 25\\:\\ 0\\.012819788909830326\ \(0\)\
\-\ labs\\:\\ 0\\.012537198096528134\ \(0\)\
\-\ now\\:\\ 0\\.012422149474011457\ \(0\)\
\-\ available\\:\\ 0\\.012277734261985258\ \(0\)\
\-\ inflammatory\\:\\ 0\\.01223648089360924\ \(0\)\
\-\ followed\\:\\ 0\\.01222012859285023\ \(0\)\
\-\ internal\\:\\ 0\\.012195757108144549\ \(0\)\
\-\ flow\\:\\ 0\\.012053333919379773\ \(0\)\
\-\ out\\:\\ 0\\.011894872618631735\ \(0\)\
\-\ no\\:\\ 0\\.011769342194440481\ \(0\)\
\-\ such\\:\\ 0\\.011640383854223715\ \(0\)\
\-\ show\\:\\ 0\\.011487870045625138\ \(0\)\
\-\ during\\:\\ 0\\.011462078526949877\ \(0\)\
\-\ severe\\:\\ 0\\.011455663278407607\ \(0\)\
\-\ some\\:\\ 0\\.011385938728345958\ \(0\)\
\-\ her\\:\\ 0\\.01130546531824318\ \(0\)\
\-\ only\\:\\ 0\\.01130546531824318\ \(0\)\
\-\ ultrasound\\:\\ 0\\.011162058333568191\ \(0\)\
\-\ primary\\:\\ 0\\.011127197111068137\ \(0\)\
\-\ when\\:\\ 0\\.010931138478978327\ \(0\)\
\-\ head\\:\\ 0\\.01079295780414984\ \(0\)\
\-\ edema\\:\\ 0\\.01079295780414984\ \(0\)\
\-\ she\\:\\ 0\\.010772223486396343\ \(0\)\
\-\ two\\:\\ 0\\.010746494721496682\ \(0\)\
\-\ 10\\:\\ 0\\.010581725671822764\ \(0\)\
\-\ months\\:\\ 0\\.010533439513987783\ \(0\)\
\-\ blood\\:\\ 0\\.010509569278542717\ \(0\)\
\-\ one\\:\\ 0\\.010360911248906961\ \(0\)\
\-\ mild\\:\\ 0\\.0102582086773255\ \(0\)\
\-\ these\\:\\ 0\\.01021890871992441\ \(0\)\
\-\ over\\:\\ 0\\.010062270426198536\ \(0\)\
\-\ consistent\\:\\ 0\\.009812162998211155\ \(0\)\
\-\ increased\\:\\ 0\\.00978555244641801\ \(0\)\
\-\ follow\\:\\ 0\\.009755411228479997\ \(0\)\
\-\ surgery\\:\\ 0\\.009729270556421634\ \(0\)\
\-\ bilateral\\:\\ 0\\.0097255536968013\ \(0\)\
\-\ without\\:\\ 0\\.009545053405475146\ \(0\)\
\-\ woman\\:\\ 0\\.009424548547024772\ \(0\)\
\-\ demonstrate\\:\\ 0\\.009407701246021357\ \(0\)\
\-\ other\\:\\ 0\\.009397635644801361\ \(0\)\
\-\ lower\\:\\ 0\\.009247166607410954\ \(0\)\
\-\ multiple\\:\\ 0\\.008851234389616014\ \(0\)\
\-\ also\\:\\ 0\\.008511923396049057\ \(0\)\
\-\ which\\:\\ 0\\.008228512077564138\ \(0\)\
\-\ not\\:\\ 0\\.007143940518099846\ \(0\)\
\-\ was\\:\\ 0\\.006306697111137603\ \(0\)\
\-\ left\\:\\ 0\\.006173000912834738\ \(0\)\
